(LEAD) S. Korea begins using remdesivir for COVID-19 treatment
(ATTN: ADDS more info throughout, photo)
SEOUL, July 1 (Yonhap) -- South Korea on Wednesday began providing remdesivir, an experimental drug conventionally used for Ebola, as a treatment drug for the novel coronavirus.
The Korea Centers for Disease Control and Prevention (KCDC) said the medication developed by U.S. pharmaceutical giant Gilead Sciences Inc. will be used for COVID-19 patients with severe symptoms.

This Yonhap file photo shows remdesivir, an experimental drug conventionally used for Ebola by U.S. pharmaceutical giant Gilead Sciences Inc. (Yonhap)
Coronavirus patients with symptoms of pneumonia who need oxygen treatment such as extracorporeal membrane oxygenation (ECMO) will be administered the drug.
The KCDC said it signed an agreement with Gilead Sciences, with details of the imported amount and price not to be disclosed.
"Health authorities will make utmost efforts to secure the treatment by cooperating with Gilead Science Korea, a local importer, to secure additional amounts of remdesivir," KCDC chief Jeong Eun-kyeong said in a press release.
Last month, the Ministry of Food and Drug Safety, South Korea's drug safety watchdog, approved the use of remdesivir as a treatment drug for COVID-19, allowing special imports by using its special measures procedure.
The U.S. National Institutes of Health (NIH) released a report saying that COVID-19 patients who received remdesivir recovered faster than similar patients who received a placebo.
The trial study, the first clinical trial launched in the United States to evaluate an experimental treatment for COVID-19, was conducted on a total of 1,063 patients.
Preliminary results indicate that patients who received remdesivir had a 31 percent faster recovery time than those who received a placebo, according to the NIH.
khj@yna.co.kr
(END)
-
(Yonhap Interview) BTS producer encourages anticipation for future messages from group
-
BLACKPINK star Jisoo tests positive for COVID-19, to miss world tour stop in Osaka
-
(News Focus) From hip-hop idols to global superstars, BTS shatters records over decade
-
3 EXO members file antitrust complaint against SM Entertainment
-
(LEAD) N. Korea releases rare photos of botched spy satellite launch
-
(Yonhap Interview) BTS producer encourages anticipation for future messages from group
-
Fifty Fifty chart on Billboard Hot 100 for 10th week with 'Cupid'
-
BLACKPINK star Jisoo tests positive for COVID-19, to miss world tour stop in Osaka
-
(News Focus) From hip-hop idols to global superstars, BTS shatters records over decade
-
(LEAD) 4 Chinese, 4 Russian military planes enter S. Korea's air defense zone without notice: S. Korean military
-
Yoon gov't unveils National Security Strategy highlighting N.K. threat
-
S. Korea expresses 'stern' protest to China, Russia over air defense zone incursion
-
4 Chinese, 4 Russian military planes enter S. Korea's air defense zone without notice: S. Korean military
-
(3rd LD) S. Korea wins seat on U.N. Security Council for 2024-25
-
(2nd LD) S. Korea wins seat on U.N. Security Council for 2024-25